-
Health Advisory: Pertussis Increase in Washington State
Current Situation in Washington There have been a total of 170 confirmed and probable cases reported statewide during 2024 through 5/4/2024 (CDC Week 18), compared to 24 cases reported by CDC Week 18 in 2023, an increase of 6-fold. Multiple jurisdictions have reported increases. Current information about pertussis in Washington can be found in the…
-
Health Advisory: CDC endorses second booster dose of mRNA COVID-19 vaccine for certain groups
Requested Actions Be aware, Centers for Disease Control and Prevention (CDC) and Western States Scientific Safety Review Workgroup endorsed Food and Drug Administration’s (FDA’s) emergency use authorization (EUA) of a second booster dose of Pfizer or Moderna COVID-19 vaccines for specific groups. The EUA allows: A second booster dose of Pfizer COVID-19 vaccine at least…
-
03/30/22 Health Advisory: CDC endorses second booster dose of mRNA COVID-19 vaccine for certain groups
Advisory or Update, Communicable Disease and Immunization Update, Health Advisory, News and Alerts, Notifiable Conditions, Provider ResourcesRequested actions Be aware, Centers for Disease Control and Prevention (CDC) and Western States Scientific Safety Review Workgroup endorsed Food and Drug Administration’s (FDA’s) emergency use authorization (EUA) of a second booster dose of Pfizer or Moderna COVID-19 vaccines for specific groups. The EUA allows: A second booster dose of Pfizer COVID-19 vaccine at least…
-
FDA Issued Emergency Use Authorization for Pfizer’s Paxlovid
Requested Actions Be aware, the S. Food and Drug Administration issued an emergency use authorization (EUA) for Pfizer’s Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for treatment of mild-to-moderate coronavirus disease (COVID-19) in adults and pediatric patients (12 years of age and older weighing at least 40 kilograms or about 88 pounds)…
-
Health Advisory: Increase in Syphilis Cases in Yakima County
Requested Actions Be aware, Yakima County reported a 326% increase in syphilis cases in 2021 compared to 2020. Optimize syphilis surveillance in pregnancy to reduce the risk of congenital syphilis. Test all women in the first trimester or at presentation to care if presenting after the first trimester Test all high-risk women again in the…
-
03/07/22 Health Advisory: Update on Johnson & Johnson vaccine ordering and guidance for healthcare settings
Advisory or Update, COVID-19, Health Advisory, Immunizations, News and Alerts, Notifiable Conditions, Provider ResourcesRequested actions Be aware, on March 4, Washington State Department of Health (DOH) discontinued ordering Johnson & Johnson COVID-19 vaccine because inventory is very low at Centers for Disease Control and Prevention (CDC) in Washington Immunization Information System (IIS). We encourage providers to post and look for available doses on IIS vaccine advertisement page. Email…
-
02/25/22 Health Advisory: COVID-19 Updates for Providers
Requested actions Be aware, on Feb. 22, Centers for Disease Control and Prevention (CDC) revised its COVID-19 vaccine clinical considerations. An 8-week interval between first and second doses of mRNA COVID-19 vaccine (Moderna and Pfizer) may be optimal for males 12–39 years old to reduce risk of myocarditis and increase efficacy. CDC still recommends a…
-
02/14/22 Health Advisory: CDC Updated Covid-19 Vaccination Guidelines; FDA Postponed its pediatric Covid-19 Vaccination Review
COVID-19 Updates for Providers Requested actions Be aware, on February 11, the Centers for Disease Control and Prevention updated their guidance for COVID-19 vaccination to include: For people who are moderately or severely immunocompromised: People who have completed a primary series of an mRNA vaccine (Pfizer-BioNTech or Moderna) are recommended to receive an mRNA booster…
-
Urgent Notice: New Communicable Disease Fax Line
Communicable Disease Data Report, Health Alert, News and Alerts, News and Update, Notifiable ConditionsThe Communicable Disease department at the Yakima Health District has a new fax line to report notifiable conditions and communicable diseases. The new fax line is (509) 381-3526. The Yakima Health District investigates approximately 100 communicable diseases and conditions that are reportable to the local health jurisdiction. To report a notifiable condition, use the Notifiable…
-
Uninsured Care Expansion Grant and Patient Resources for Individuals Experiencing Long COVID-19
Requested Actions Be aware the Health Care Authority (HCA) has received $35 million in federal resources for the provision of health care services for uninsured and underinsured individuals under 200 percent of the federal poverty level, regardless of immigration status. Be aware the University of Washington Medicine has a Post-COVID-19 Rehabilitation and Recovery clinic to…
-
02/01/22 Health Advisory: FDA Provides Full Approval For Spikevax
Advisory or Update, Communicable Disease and Immunization Update, COVID-19, Health Advisory, Notifiable Conditions, Provider Resources, UncategorizedCOVID-19 Updates for Providers Requested actions Be aware, U.S. Food and Drug Administration (FDA) granted full authorization to Moderna COVID-19 vaccine for people 18 years or older. Evidence shows the vaccine is safe and effective and manufactured with high quality. The vaccine will now be called Spikevax but has the same formulation as emergency use…
-
01/06/22 Health Advisory: Booster Eligibility Expanded
Advisory or Update, Communicable Disease and Immunization Update, COVID-19, Health Advisory, Immunizations, News and Alerts, Notifiable Conditions, Provider ResourcesCOVID-19 Updates for Providers Requested actions Be aware, Centers for Disease Control and Prevention (CDC) endorsed Advisory Committee on Immunization Practices’ (ACIP’s) decision to strongly recommend a single Pfizer COVID-19 vaccine booster dose for people 12–17 years old at least 5 months after their primary series. This expands the age of booster access and strengthens…
-
Health Advisory: COVID-19 Isolation and Quarantine Update
01/05/2022 Requested actions Be aware the CDC has indicated the guidance released last week was intended for the general public, and they will be releasing additional I&Q guidance for some congregant settings soon. Be aware WA DOH recommends that people staying, working/learning in the following settings continue to follow existing DOH and CDC guidance until…